News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
FDA Approval Announced for Higher Dose of Donepezil Hydrochloride for Moderate to Severe Alzheimer’s Disease
July 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The FDA has approved the first generic low molecular weight heparin product -- a generic version of Lovenox (enoxaparin sodium injection) for the prevention of deep vein thrombosis.
Twitter
LinkedIn
Facebook
Email
Print